Loading clinical trials...
Loading clinical trials...
Study to Generate Exploratory Training Data Characterising Innate/ Adaptive Immune Responses Following 1st & 3rd Intra-muscular Immunisations With Fendrix/Engerix B Vaccines in Healthy Adult Males With no Pre-existing Immunity to Hep B
Conditions
Interventions
Engerix B IM injection - 20ug
Fendrix IM injection - 20ug
Locations
1
United Kingdom
Surrey Clinical Research Centre
Guildford, Surrey, United Kingdom
Start Date
May 1, 2014
Primary Completion Date
February 1, 2016
Completion Date
February 1, 2016
Last Updated
February 8, 2016
NCT07024641
NCT06671093
NCT07275554
NCT03826433
NCT06885710
NCT06947499
Lead Sponsor
University of Surrey
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions